# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-24-000091
Filing Date
2024-11-04
Accepted
2024-11-04 06:57:19
Documents
5
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-kq32024quarterlyrepo.htm | 6-K | 18177
2 | EX-99.1 | bnt_2024q3ex99x1quarterlyr.htm | EX-99.1 | 2133753
3 | EX-99.2 | a992biontechsearticlesofas.htm | EX-99.2 | 79477
4 |  | a230530_ihub-labxshootingx.jpg | GRAPHIC | 1012449
5 |  | biontech_logoxforestgreen2.jpg | GRAPHIC | 19001
| Complete submission text file | 0001776985-24-000091.txt |  | 3653026

Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 241420717
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)